People · Operator
Named in public records as an officer, director or promoter · active 2022–2022 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Astrocyte Pharmaceuticals Inc. | — | Pharmaceuticals | Series A | $12.8M | $31.6M | 2022 |
Jeffrey S. Ives at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Jeffrey S. Ives on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Jeffrey Arnold | 1 | 5 |
| Jeffrey L. Ives | 1 | 3 |
| Jeffrey Ives | 1 | 2 |
| Jeffrey S. Arnold | 1 | 1 |
| Jackson S. Streeter | 1 | 1 |
| William Korinek | 1 | 1 |
| James D. Lechleiter | 1 | 1 |
| William S. Korinek | 1 | 1 |
| Christine S. Gallagher | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.